Compare Kinross Gold Corporation (KGC) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinross Gold Corporation vs Moderna, Inc. — how do they compare? Kinross Gold Corporation trades at $23.41 (market cap $26.63B), while Moderna, Inc. trades at $59.73 (market cap $23.60B). The key difference: Kinross Gold Corporation and Moderna, Inc. are close in size by market cap, and Kinross Gold Corporation pays a 0.64% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| KGC | MRNA | |
|---|---|---|
Market Cap | $26.63B | $23.60B |
Sector | Basic Materials | Health |
52-Week High | $38.06 | $81.80 |
52-Week Low | $15.42 | $22.36 |
Enterprise Value | $25.18B | $19.70B |
Dividend Yield | 0.64% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kinross Gold Corporation
Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
